We use cookies to improve your experience. By continuing to browse this site, you accept our cookie policy.×
Skip main navigation
Aging Health
Bioelectronics in Medicine
Biomarkers in Medicine
Breast Cancer Management
CNS Oncology
Colorectal Cancer
Concussion
Epigenomics
Future Cardiology
Future Medicine AI
Future Microbiology
Future Neurology
Future Oncology
Future Rare Diseases
Future Virology
Hepatic Oncology
HIV Therapy
Immunotherapy
International Journal of Endocrine Oncology
International Journal of Hematologic Oncology
Journal of 3D Printing in Medicine
Lung Cancer Management
Melanoma Management
Nanomedicine
Neurodegenerative Disease Management
Pain Management
Pediatric Health
Personalized Medicine
Pharmacogenomics
Regenerative Medicine

Effects of major human antiprotease α-1-antitrypsin on the motility and proliferation of stromal cells from human exfoliated deciduous teeth

    ,
    Virginijus Tunaitis

    State Institute of Science “Centre of Innovative Medicine”, Vilnius University, Zygimantu 9, Vilnius LT-01102, Lithuania

    ,
    Andrejus Surovas

    State Institute of Science “Centre of Innovative Medicine”, Vilnius University, Zygimantu 9, Vilnius LT-01102, Lithuania

    ,
    Kristina Suriakaite

    State Institute of Science “Centre of Innovative Medicine”, Vilnius University, Zygimantu 9, Vilnius LT-01102, Lithuania

    ,
    Akvile Jarmalaviciute

    State Institute of Science “Centre of Innovative Medicine”, Vilnius University, Zygimantu 9, Vilnius LT-01102, Lithuania

    ,
    Karl-Eric Magnusson

    Division of Medical Microbiology, Linkoping University, Linkoping, Sweden

    &
    Augustas Pivoriunas

    State Institute of Science “Centre of Innovative Medicine”, Vilnius University, Zygimantu 9, Vilnius LT-01102, Lithuania

    Published Online:https://doi.org/10.2217/rme.10.18

    Aim: Intrinsic tissue regeneration mechanisms are still not fully understood. The destruction/reconstruction processes are usually in fine balance; however, this can be easily destroyed, for example in the environment of chronic inflammation. One of the major proteins present at the inflammatory sites is the multifunctional protein α-1-antitrypsin (AAT). In this study, potential therapeutic effects of this major human antiprotease on progenitor cells are assessed. Materials & methods: Stromal cells from human exfoliated deciduous teeth (SHEDs) were used, which are similar to the mesenchymal stromal cells isolated from other tissues. SHEDs were cultivated in the presence of subphysiological, physiological and inflammatory concentrations of AAT, and their proliferation and motility traits were assayed. Some intracellular signaling pathways, AAT internalization by SHEDs and their matrix metalloprotease profile were studied in parallel. Results: Physiologic and inflammatory concentrations of AAT significantly increased the cell proliferation rate, induced phosphorylation of several key protein kinases and increased the amount of secreted active gelatinases. Moreover, cells exposed to physiologic and inflammatory levels of AAT were able to invade and migrate more efficiently. Subphysiologic AAT levels did not change cell behavior significantly. Conclusion: AAT at physiologic and inflammatory concentrations positively modulates the proliferation and motility of SHEDs in vitro. These results suggest the importance of AAT in the maintenance and regulation of tissue progenitor cells in vivo.

    Papers of special note have been highlighted as:▪ of interest ▪▪ of considerable interest

    Bibliography

    • Ksiazek K: A comprehensive review on mesenchymal stem cell growth and senescence. Rejuvenation Res.12(2),105–116 (2009).
    • Prockop DJ: Marrow stromal cells as stem cells for nonhematopoietic tissues. Science276(5309),71–74 (1997).
    • Meirelles LDS, Chagastelles PC, Nardi NB: Mesenchymal stem cells reside in virtually all postnatal organs and tissues. J. Cell Sci.119(11),2204–2213 (2006).
    • Bianco P, Robey PG, Simmons PJ: Mesenchymal stem cells: revisiting history, concepts, and assays. Cell Stem Cell2(4),313–319 (2008).
    • Pittenger MF, Mackay AM, Beck SC et al.: Multilineage potential of adult human mesenchymal stem cells. Science284(5411),143–147 (1999).
    • Bieback K, Kern S, Kocaömer A, Ferlik K, Bugert P: Comparing mesenchymal stromal cells from different human tissues: bone marrow, adipose tissue and umbilical cord blood. Biomed. Mat. Eng.18,71–76 (2008).
    • Dominici M, Le Blanc K, Mueller I et al.: minimal criteria for defining multipotent mesenchymal stromal cells. The international society for cellular therapy position statement. Cytotherapy8(4),315–317 (2006).
    • Miura M, Gronthos S, Zhao M et al.: SHED: stem cells from human exfoliated deciduous teeth. Proc. Natl Acad. Sci. USA100(10),5807–5812 (2003).▪ Stem cells from exfoliated deciduous teeth are well characterized.
    • Huang GTJ, Gronthos S, Shi S: Mesenchymal stem cells derived from dental tissues vs. those from other sources: their biology and role in regenerative medicine. J. Dental Res.88(9),792–806 (2009).
    • 10  Pivoriunas A, Surovas A, Borutinskaite V et al.: Proteomic analysis of stromal cells derived from the dental pulp of human exfoliated deciduous teeth. Stem Cells Dev. (2009) (Epub ahead of print).
    • 11  Gnecchi M, Zhang Z, Ni A, Dzau VJ: Paracrine mechanisms in adult stem cell signaling and therapy. Circ. Res.103(11),1204–1219 (2008).
    • 12  Belmadani A, Tran PB, Ren D, Miller RJ: Chemokines regulate the migration of neural progenitors to sites of neuroinflammation. J. Neurosci.26(12),3182–3191 (2006).
    • 13  Hiemstra PS: Novel roles of protease inhibitors in infection and inflammation. Biochem. Soc. Trans.30(2),116–120 (2002).
    • 14  Roghanian A, Sallenave J-M: Neutrophil elastase (NE) and NE inhibitors: canonical and noncanonical functions in lung chronic inflammatory diseases (cystic fibrosis and chronic obstructive pulmonary disease). J. Aerosol Med. Pulm. Drug Deliv.21(1),125–144 (2008).
    • 15  Gadek J, Pacht E: The protease-antiprotease balance within the human lung: implications for the pathogenesis of emphysema. Lung168,552–564 (1990).
    • 16  Eriksson S: Discovery of α-1-antitrypsin deficiency. Lung (168),523–529 (1990).
    • 17  Dabbagh K, Laurent JG, Shock A, Leoni P, Papakrivopoulou J, Chambers CR: α-1-antitrypsin stimulates fibroblast proliferation and procollagen production and activates classical MAP kinase signalling pathways. J. Cell. Physiol.186(1),73–81 (2001).▪▪ The ability of α-1-antitrypsin to activate intracellular signaling cascades is demonstrated.
    • 18  Parmar JS, Mahadeva R, Reed BJ et al.: Polymers of α-1-antitrypsin are chemotactic for human neutrophils. A new paradigm for the pathogenesis of emphysema. Am. J. Respir. Cell Mol. Biol.26(6),723–730 (2002).
    • 19  Libert C, Van Molle W, Brouckaert P, Fiers W: α-1-antitrypsin inhibits the lethal response to TNF in mice. J. Immunol.157(11),5126–5129 (1996).
    • 20  Pott GB, Chan ED, Dinarello CA, Shapiro L: α-1-antitrypsin is an endogenous inhibitor of proinflammatory cytokine production in whole blood. J. Leukoc. Biol.85(5),886–895 (2009).
    • 21  Petrache I, Fijalkowska I, Medler TR et al.: α-1 antitrypsin inhibits caspase-3 activity, preventing lung endothelial cell apoptosis. Am. J. Pathol.169(4),1155–1166 (2006).▪ The uptake of α-1-antitrypsin by lung structural cells is proven.
    • 22  Aldonyte R, Hutchinson ET, Jin B et al.: Endothelial α-1-antitrypsin attenuates cigarette smoke induced apoptosis in vitro.COPD5(3),153–162 (2008).
    • 23  Nakhleh R, Snover D: Use of α-1-antitrypsin staining in the diagnosis of nodular regenerative hyperplasia of the liver. Hum. Pathol.19(9),1048–1052 (1988).
    • 24  Carlson JA, Rogers BB, Sifers RN, Hawkins HK, Finegold MJ, Woo SL: Multiple tissues express α-1-antitrypsin in transgenic mice and man. J. Clin. Invest.82(1),26–36 (1988).
    • 25  Senn O, Russi E, Schindler C et al.: Circulating α-1-antitrypsin in the general population: Determinants and association with lung function. Respir. Res.9(1),35 (2008).
    • 26  Dati F, Johnson AM, Whicher JT: The existing interim consensus reference ranges and the future approach. Clin. Chem. Lab. Med.39,1134 – 1136 (2001).
    • 27  Dhainaut J-F, Marin N, Mignon A, Vinsonneau C: Hepatic response to sepsis: interaction between coagulation and inflammatory processes. Crit. Care Med.29(7),S42-S47 (2001).
    • 28  Perlmutter DH, Punsal PI: Distinct and additive effects of elastase and endotoxin on expression of α-1 proteinase inhibitor in mononuclear phagocytes. J. Biol. Chem.263(31),16499–16503 (1988).
    • 29  Knoell DL, Ralston DR, Coulter KR, Wewers MD: α-1-antitrypsin and protease complexation is induced by lipopolysaccharide, interleukin-1α, and tumor necrosis factor-α in monocytes. Am. J. Respir. Crit. Care Med.157(1),246–255 (1998).
    • 30  Hubbard RC, Crystal RG: α-1-antitrypsin augmentation therapy for α-1-antitrypsin deficiency. Am. J. Med.84,52–62 (1988).
    • 31  Mungall BA, Pollitt CC, Collins R: Localisation of gelatinase activity in epidermal hoof lamellae by in situ zymography. Histochem. Cell Biol.110(5),535–540 (1998).
    • 32  Gunawardane RN, Sgroi DC, Wrobel CN, Koh E, Daley GQ, Brugge JS: Novel role for PDEF in epithelial cell migration and invasion. Cancer Res.65(24),11572–11580 (2005).
    • 33  Aldonyte R, Jansson L, Ljungberg O, Larsson S, Janciauskiene S: Polymerized α-1-antitrypsin is present on lung vascular endothelium. New insights into the biological significance of α-1-antitrypsin polymerization. Histopathology45(6),587–592 (2004).
    • 34  Pascale J, Sybille L-H, Yves D, Jean-François G, Jean-Yves B: α-1 antitrypsin up-regulates human B cell differentiation selectively into IGE- and IGG4-secreting cells. Eur. J. Immunol.28(6),1815–1822 (1998).
    • 35  Soo C, Shaw WW, Zhang X, Longaker MT, Howard EW, Ting K: Differential expression of matrix metalloproteinases and their tissue-derived inhibitors in cutaneous wound repair. Plast. Reconstr. Surg.105(2),638–647 (2000).
    • 36  Ruiz V, Ordonez RM, Berumen J et al.: Unbalanced collagenases/TIMP-1 expression and epithelial apoptosis in experimental lung fibrosis. Am. J. Physiol. Lung Cell Mol. Physiol.285(5),L1026–1036 (2003).
    • 37  Holmbeck K, Bianco P, Chrysovergis K, Yamada S, Birkedal-Hansen H: Mt1-MMP-dependent, apoptotic remodeling of unmineralized cartilage: a critical process in skeletal growth. J. Cell Biol.163(3),661–671 (2003).
    • 38  Schäfer-Somi S, Beceriklisoy HB, Budik S et al.: Expression of genes in the canine preimplantation uterus and embryo: implications for an active role of the embryo before and during invasion. Reprod. Domest. Anim.43(6),656–663 (2008).
    • 39  Balbin M, Fueyo A, Knauper V et al.: Collagenase 2 (MMP-8) expression in murine tissue-remodeling processes. J. Biol. Chem.273(37),23959–23968 (1998).
    • 40  Georges B, Laurent M, Arnaud R: Matrix metalloproteinases and matrikines in angiogenesis. Crit. Rev. Oncol. Hematol.49(3),203–220 (2004).
    • 41  Sabeh F, Shimizu-Hirota R, Weiss SJ: Protease-dependent versus -independent cancer cell invasion programs: three-dimensional amoeboid movement revisited. J. Cell Biol.185(1),11–19 (2009).
    • 42  Lapidot T, Dar A, Kollet O: How do stem cells find their way home? Blood106(6),1901–1910 (2005).
    • 43  Toker A: Akt signaling: a damaging interaction makes good. Trends Biochem. Sci.33(8),356–359 (2008).
    • 44  Manning B, Cantley L: Akt/PKB signaling: navigating downstream. Cell129(7),1261–1274 (2007).
    • 45  Raman M, Chen W, Cobb MH: Differential regulation and properties of MAPKs. Oncogene26(22),3100–3112 (2007).
    • 46  Wang Q: PKD at the crossroads of DAG and PKC signaling. Trends Pharmacol. Sci.27(6),317–323 (2006).
    • 47  Prestle J, Pfizenmaier K, Brenner J, Johannes FJ: Protein kinase C MU is located at the golgi compartment. J. Cell Biol.134(6),1401–1410 (1996).
    • 48  Rozengurt E, Rey O, Waldron RT: Protein kinase D signaling. J. Biol. Chem.280(14),13205–13208 (2005).
    • 49  Woods AJ, White DP, Caswell PT, Norman JC: PKD1/PKCm promotes ava3 integrin recycling and delivery to nascent focal adhesions. EMBO J.23(13),2531–2543 (2004).
    • 50  Vertommen D, Rider M, Ni Y et al.: Regulation of protein kinase D by multisite phosphorylation. J. Biol. Chem.275(26),19567–19576 (2000).
    • 51  Lemonnier JR, Ghayor C, Guicheux JR, Caverzasio J: Protein kinase C-independent activation of protein kinase D is involved in BMP-2-induced activation of stress mitogen-activated protein kinases Jnk and p38 and osteoblastic cell differentiation. J. Biol. Chem.279(1),259–264 (2004).